Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Jesse Schold to Graft Survival

This is a "connection" page, showing publications Jesse Schold has written about Graft Survival.

 
Connection Strength
  
 
 
7.935
  
  1. Tsuang WM, Arrigain S, Lopez R, Snair M, Budev M, Schold JD. Patient Travel Distance and Post Lung Transplant Survival in the United States: A Cohort Study. Transplantation. 2020 11; 104(11):2365-2372.
    View in: PubMed
    Score: 0.617
  2. Tsuang WM, Lin S, Valapour M, Udeh BL, Budev M, Schold JD. The Association Between Lung Recipient Travel Distance and Posttransplant Survival. Prog Transplant. 2018 09; 28(3):231-235.
    View in: PubMed
    Score: 0.524
  3. Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J. Low testosterone at time of transplantation is independently associated with poor patient and graft survival in male renal transplant recipients. J Urol. 2014 Oct; 192(4):1168-71.
    View in: PubMed
    Score: 0.391
  4. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant. 2011 Dec; 11(12):2657-64.
    View in: PubMed
    Score: 0.331
  5. Kayler LK, Magliocca J, Zendejas I, Srinivas TR, Schold JD. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant. 2011 Dec; 11(12):2647-56.
    View in: PubMed
    Score: 0.327
  6. Braun WE, Schold JD. Transplantation: strength in numbers-predicting long-term transplant outcomes. Nat Rev Nephrol. 2011 Mar; 7(3):135-6.
    View in: PubMed
    Score: 0.314
  7. Kayler LK, Sokolich J, Magliocca J, Schold JD. Import kidney transplants from nonmandatory share deceased donors: characteristics, distribution and outcomes. Am J Transplant. 2011 Jan; 11(1):77-85.
    View in: PubMed
    Score: 0.312
  8. Schold JD, Srinivas TR, Braun WE, Shoskes DA, Nurko S, Poggio ED. The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing age. Clin Transplant. 2011 Sep-Oct; 25(5):721-30.
    View in: PubMed
    Score: 0.308
  9. Schold JD, Santos A, Rehman S, Magliocca J, Meier-Kriesche HU. The success of continued steroid avoidance after kidney transplantation in the US. Am J Transplant. 2009 Dec; 9(12):2768-76.
    View in: PubMed
    Score: 0.287
  10. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation. 2009 Jul 15; 88(1):23-9.
    View in: PubMed
    Score: 0.282
  11. Kaplan B, Schold J. Transplantation: neural networks for predicting graft survival. Nat Rev Nephrol. 2009 Apr; 5(4):190-2.
    View in: PubMed
    Score: 0.276
  12. Kayler LK, Garzon P, Magliocca J, Fujita S, Kim RD, Hemming AW, Howard R, Schold JD. Outcomes and utilization of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2009 Feb; 9(2):367-73.
    View in: PubMed
    Score: 0.273
  13. Schold JD, Mohan S, Jackson WE, Stites E, Burton JR, Bababekov YJ, Saben JL, Pomposelli JJ, Pomfret EA, Kaplan B. Differential in Kidney Graft Years on the Basis of Solitary Kidney, Simultaneous Liver-Kidney, and Kidney-after-Liver Transplants. Clin J Am Soc Nephrol. 2024 03 01; 19(3):364-373.
    View in: PubMed
    Score: 0.190
  14. Schold JD, Huml AM, Husain SA, Mohan S. Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation. J Am Soc Nephrol. 2023 10 01; 34(10):1615-1617.
    View in: PubMed
    Score: 0.186
  15. Schold JD. The promise and reality of machine-learning models in kidney transplantation. Kidney Int. 2023 05; 103(5):835-836.
    View in: PubMed
    Score: 0.183
  16. Schold JD, Huml AM, Husain SA, Poggio ED, Buchalter RB, Lopez R, Kaplan B, Mohan S. Deceased donor kidneys from higher distressed communities are significantly less likely to be utilized for transplantation. Am J Transplant. 2023 11; 23(11):1723-1732.
    View in: PubMed
    Score: 0.182
  17. Schold JD, Nordyke RJ, Wu Z, Corvino F, Wang W, Mohan S. Clinical Events and Renal Function in the First Year Predict Long-Term Kidney Transplant Survival. Kidney360. 2022 04 28; 3(4):714-727.
    View in: PubMed
    Score: 0.168
  18. Husain SA, King KL, Sanichar N, Crew RJ, Schold JD, Mohan S. Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant. JAMA Netw Open. 2021 04 01; 4(4):e215718.
    View in: PubMed
    Score: 0.159
  19. Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD. Long-term kidney transplant graft survival-Making progress when most needed. Am J Transplant. 2021 08; 21(8):2824-2832.
    View in: PubMed
    Score: 0.157
  20. Kumar S, Lin S, Schold JD. Impact of donation after circulatory death donor allografts on outcomes following liver transplantation for fulminant hepatic failure in the United States. Am J Transplant. 2021 01; 21(1):382-390.
    View in: PubMed
    Score: 0.154
  21. Schold JD, Augustine JJ, Huml AM, Fatica R, Nurko S, Wee A, Poggio ED. Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics. Am J Transplant. 2021 02; 21(2):751-765.
    View in: PubMed
    Score: 0.152
  22. Schold JD, Augustine JJ, Huml AM, O'Toole J, Sedor JR, Poggio ED. Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant. 2020 03; 20(3):769-778.
    View in: PubMed
    Score: 0.144
  23. Sasaki K, Firl DJ, McVey JC, Schold JD, Iuppa G, Diago Uso T, Fujiki M, Aucejo FN, Quintini C, Eghetsad B, Miller CM, Hashimoto K. Elevated Risk of Split-Liver grafts in adult liver Transplantation: Statistical Artifact or Nature of the Beast? Liver Transpl. 2019 05; 25(5):741-751.
    View in: PubMed
    Score: 0.138
  24. O'Connell PJ, Kuypers DR, Mannon RB, Abecassis M, Chadban SJ, Gill JS, Murphy B, Nickerson PW, Schold JD, Stock PG, Seron D, Alloway RR, Bromberg JS, Budde K, Jordan SC, Legendre C, Lefaucheur C, Sarwall M, Segev DL, Stegall MD, Tullius SG, Wong G, Woodle ES, Ascher N, Morris RE. Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Transplantation. 2017 07; 101(7):1527-1534.
    View in: PubMed
    Score: 0.122
  25. Schold J, Poggio E, Goldfarb D, Kayler L, Flechner S. Clinical outcomes associated with induction regimens among retransplant kidney recipients in the United States. Transplantation. 2015 Jun; 99(6):1165-71.
    View in: PubMed
    Score: 0.106
  26. Schold JD, Buccini LD, Reese PP, Poggio ED, Goldfarb DA. Effect of dialysis initiation for preemptively listed candidates in the revised kidney allocation policy. Am J Transplant. 2014 Dec; 14(12):2855-60.
    View in: PubMed
    Score: 0.101
  27. Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD. The impact of deceased donor kidney risk significantly varies by recipient characteristics. Am J Transplant. 2013 Apr; 13(4):1001-1011.
    View in: PubMed
    Score: 0.090
  28. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Hsich E, Mason D, Fung J, Stephany BR, Krishnamurthi V, Srinivas TR. Patient participation in research among solid organ transplant recipients in the United States. Transplantation. 2011 Jun 27; 91(12):1424-35.
    View in: PubMed
    Score: 0.081
  29. Schold JD, Arrington CJ, Levine G. Significant alterations in reported clinical practice associated with increased oversight of organ transplant center performance. Prog Transplant. 2010 Sep; 20(3):279-87.
    View in: PubMed
    Score: 0.076
  30. Kayler LK, Magliocca J, Kim RD, Howard R, Schold JD. Single kidney transplantation from young pediatric donors in the United States. Am J Transplant. 2009 Dec; 9(12):2745-51.
    View in: PubMed
    Score: 0.072
  31. Schold JD, Kaplan B. AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients. Am J Transplant. 2009 Sep; 9(9):2067-74.
    View in: PubMed
    Score: 0.071
  32. Schold JD, Rehman S, Kayle LK, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int. 2009 Jun; 22(6):626-34.
    View in: PubMed
    Score: 0.068
  33. Kayler LK, Magliocca J, Fujita S, Kim RD, Zendejas I, Hemming AW, Howard R, Schold JD. Recovery factors affecting utilization of small pediatric donor kidneys. Am J Transplant. 2009 Jan; 9(1):210-6.
    View in: PubMed
    Score: 0.067
  34. Schold JD, Srinivas TR, Howard RJ, Jamieson IR, Meier-Kriesche HU. The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation. 2008 Jan 15; 85(1):1-6.
    View in: PubMed
    Score: 0.064
  35. Schold JD, Kaplan B, Howard RJ, Reed AI, Foley DP, Meier-Kriesche HU. Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. Am J Transplant. 2005 Jul; 5(7):1681-8.
    View in: PubMed
    Score: 0.053
  36. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU. The broad spectrum of quality in deceased donor kidneys. Am J Transplant. 2005 Apr; 5(4 Pt 1):757-65.
    View in: PubMed
    Score: 0.052
  37. Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004 Aug; 4(8):1289-95.
    View in: PubMed
    Score: 0.050
  38. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004 Mar; 4(3):378-83.
    View in: PubMed
    Score: 0.049
  39. Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: a paired kidney analysis. J Am Soc Nephrol. 2003 Nov; 14(11):2980-4.
    View in: PubMed
    Score: 0.047
  40. Cooper M, Wiseman AC, Doshi MD, Hall IE, Parsons RF, Pastan S, Reddy KS, Schold JD, Mohan S, Hippen BE. Understanding Delayed Graft Function to Improve Organ Utilization and Patient Outcomes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2024 03; 83(3):360-369.
    View in: PubMed
    Score: 0.047
  41. Yu M, King KL, Husain SA, Huml AM, Patzer RE, Schold JD, Mohan S. Discrepant Outcomes between National Kidney Transplant Data Registries in the United States. J Am Soc Nephrol. 2023 11 01; 34(11):1863-1874.
    View in: PubMed
    Score: 0.047
  42. Malamon JS, Jackson WE, Saben JL, Conzen K, Schold JD, Pomposelli JJ, Pomfret EA, Kaplan B. A model for calculating the long-term estimated post-transplant survival of deceased donor liver transplant patients. EBioMedicine. 2023 Apr; 90:104505.
    View in: PubMed
    Score: 0.045
  43. Koval CE, Eltemamy M, Poggio ED, Schold JD, Wee AC. Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience. Am J Transplant. 2022 12; 22(12):2903-2911.
    View in: PubMed
    Score: 0.044
  44. Kobashigawa JA, Hall S, Farr M, Blumberg E, Michael Borkon A, Colvin M, Copeland H, Eisen H, Johnson M, Jorde U, Khush K, Kirklin JK, Patel J, Pinney S, Saadaeijahromi H, Schold JD, Stehlik J. Proceedings from the metrics forum in heart transplantation for performance monitoring. Am J Transplant. 2022 05; 22(5):1299-1306.
    View in: PubMed
    Score: 0.042
  45. Uffing A, P?rez-Sa?z MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV. Recurrence of IgA Nephropathy after Kidney Transplantation in Adults. Clin J Am Soc Nephrol. 2021 08; 16(8):1247-1255.
    View in: PubMed
    Score: 0.041
  46. Mayne TJ, Nordyke RJ, Schold JD, Weir MR, Mohan S. Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation. Clin Transplant. 2021 07; 35(7):e14326.
    View in: PubMed
    Score: 0.040
  47. Chen DP, Zaky ZS, Schold JD, Herlitz LC, El-Rifai R, Drawz PE, Bruggeman LA, Barisoni L, Hogan SL, Hu Y, O'Toole JF, Poggio ED, Sedor JR. Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation. Clin Transplant. 2021 04; 35(4):e14234.
    View in: PubMed
    Score: 0.039
  48. Braun WE, Herlitz L, Li J, Schold J, Poggio E, Stephany B, Fatica R, Nally J, Brown K, Fairchild R, Baldwin W, Goldfarb D, Kiser W, Augustine J, Avery R, Tomford JW, Nakamoto S. Continuous function of 80 primary renal allografts for 30-47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long-term successes. Clin Transplant. 2021 01; 35(1):e14131.
    View in: PubMed
    Score: 0.039
  49. Lehr CJ, Lopez R, Arrigain S, Schold J, Koval C, Valapour M. The impact of change in definition of increased-risk donors on survival after lung transplant. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):572-581.
    View in: PubMed
    Score: 0.036
  50. Husain SA, Brennan C, Michelson A, Tsapepas D, Patzer RE, Schold JD, Mohan S. Patients prioritize waitlist over posttransplant outcomes when evaluating kidney transplant centers. Am J Transplant. 2018 11; 18(11):2781-2790.
    View in: PubMed
    Score: 0.033
  51. Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL. Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation. Am J Transplant. 2017 03; 17(3):744-753.
    View in: PubMed
    Score: 0.029
  52. Snyder JJ, Salkowski N, Wey A, Israni AK, Schold JD, Segev DL, Kasiske BL. Effects of High-Risk Kidneys on Scientific Registry of Transplant Recipients Program Quality Reports. Am J Transplant. 2016 09; 16(9):2646-53.
    View in: PubMed
    Score: 0.028
  53. Bagga HS, Lin S, Williams A, Schold J, Chertack N, Goldfarb D, Wood H. Trends in Renal Transplantation Rates in Patients with Congenital Urinary Tract Disorders. J Urol. 2016 Apr; 195(4 Pt 2):1257-62.
    View in: PubMed
    Score: 0.028
  54. Elfadawy N, Flechner SM, Schold JD, Srinivas TR, Poggio E, Fatica R, Avery R, Mossad SB. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation. Clin J Am Soc Nephrol. 2014 Mar; 9(3):553-61.
    View in: PubMed
    Score: 0.024
  55. Zachariah M, Gregg A, Schold J, Magliocca J, Kayler LK. Alemtuzumab induction in simultaneous pancreas and kidney transplantation. Clin Transplant. 2013 Sep-Oct; 27(5):693-700.
    View in: PubMed
    Score: 0.023
  56. Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
    View in: PubMed
    Score: 0.020
  57. Claes K, Meier-Kriesche HU, Schold JD, Vanrenterghem Y, Halloran PF, Ekberg H. Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. Nephrol Dial Transplant. 2012 Feb; 27(2):850-7.
    View in: PubMed
    Score: 0.020
  58. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant. 2007 Jul; 7(7):1808-14.
    View in: PubMed
    Score: 0.015
  59. Lansang MC, Ma L, Schold JD, Meier-Kriesche HU, Kaplan B. The relationship between diabetes and infectious hospitalizations in renal transplant recipients. Diabetes Care. 2006 Jul; 29(7):1659-60.
    View in: PubMed
    Score: 0.014
  60. Srinivas TR, Kaplan B, Schold JD, Meier-Kriesche HU. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S211-20.
    View in: PubMed
    Score: 0.014
  61. Womer KL, Peng R, Patton PR, Murawski MR, Bucci M, Kaleem A, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ. The effects of renal transplantation on peripheral blood dendritic cells. Clin Transplant. 2005 Oct; 19(5):659-67.
    View in: PubMed
    Score: 0.014
  62. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant. 2005 Sep; 5(9):2273-80.
    View in: PubMed
    Score: 0.013
  63. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B. Kidneys from deceased donors: maximizing the value of a scarce resource. Am J Transplant. 2005 Jul; 5(7):1725-30.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)